Your browser doesn't support javascript.
loading
Structural modeling of V299L and E459K Bcr-Abl mutation, and sequential therapy of tyrosine kinase inhibitors for the compound mutations.
Kim, Dongho; Kim, Dong-Wook; Cho, Byung-Sik; Goh, Hyun-Gyung; Kim, Soo-Hyun; Kim, Wan-Seok; Lee, Jeong; Kweon, Il-Young; Park, Sa-Hee; Yoon, Jeong Hyeok; Kim, Nam Doo; Chun, Haarin.
Afiliação
  • Kim D; Molecular Hematology Research Laboratory, The Catholic Research Institute of Medical Science, The Catholic University of Korea, Seoul, Republic of Korea.
Leuk Res ; 33(9): 1260-5, 2009 Sep.
Article em En | MEDLINE | ID: mdl-19201023

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Limite: Adult / Humans / Male Idioma: En Ano de publicação: 2009 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Limite: Adult / Humans / Male Idioma: En Ano de publicação: 2009 Tipo de documento: Article